Stroke Management Market

By Type (Ischemic Stroke, Hemorrhagic Stroke, Others),
By Treatment (Anti-Coagulants and Anti-Platelets),
By Diagnosis (Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Electrocardiography, Ultrasound, Cerebral Angiography, and  Others),
By Therapy (Embolic Coils, Stent Receiver, Surgical Clips, Aspiration Catheters, Others),
By End Use (Hospitals and Surgery Centers, Diagnostic Centers, and Others),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):

Global Analysis and Forecast 2023-2033.

Domain:
Healthcare and Pharma
Report Code:
HCP22014
Published Date:
July 2023

The global stroke management market to worth more than USD 71 billion by 2033.

A drastic shift towards lifestyle, a rise in the geriatric population, increasing prevalence of blood disorders such as thromboembolism or hypertension are primary factors supporting the market growth of Stroke management. With the insights given by new studies conducted on stroke, it has become evident that lifestyle factors combined with genetics are likely to affect higher stroke rates. Genetic factors can be altered by lifestyles inclining towards the poor end, triggering more stroke cases per year. The geriatric population is most likely to develop stroke due to high blood pressure or diabetes. Stroke is also linked to other disease states, such as asthma and PTSD. These interlinked studies delve deeper into the role of plaque development and stress in contributing to stroke development. Smoking is also linked to increased blood clotting or fatty acid deposition. New studies are focusing on better diagnostic and treatment approaches, further fueling the stroke management market. For instance, MRIs are on receiving end of technological innovation within the forecasted timeframe in terms of integration with AI and improved image quality.

The companies operating within the stroke management market are undergoing mergers, collaboration, acquisition, long-term contracts, and service agreements to increase their global footprint. For instance, Abbott has partnered with Americares India Foundation to upgrade 75 Primary Health Centres (PHCs) to Health and Wellness Centres (HWCs) across nine states in India. This would be helpful in addressing rising stroke cases within the country. Furthermore, notable investment towards research and development to launch new and innovative products that support diagnosis and treatment at multiple levels is also practiced by market stakeholders.

According to the CXOs and primary research conducted, COVID-19 has significantly influenced stroke risks. The pandemic was plagued with stress for all sections of populations, thus increasing the chances of cardiovascular risks and blood disorders. COVID-19 has also opened up new vigorous horizons of research and development to keep healthcare advanced and efficient. Lifestyle shift post-pandemic has pushed people to a sudden wave of movement again, causing more complexities for geriatric populations.

The stroke management market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In line with the analyzed region, the North American region will witness the highest market share, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The gradual rise in geratric population within the U.S. and increasing cases of depression and other health realted diseases in the U.S. due to the lifestye and food habits will attribute to high cases of heart stroke, generating the demand of stroke management systems. The major companies operating within the market are Abbott, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Cardinal Health Inc., GE Healthcare, Johnson & Johnson Services, Inc., Koninklijke Philips N.V. Boston Scientific Corporation, Medtronic and Siemens.

Related Reports

No items found.
Contact:
Dhvanil Dave
Quadrant Market Insights
+1-909-488-5693
query@quadrantmarketinsights.com